References
- Achari AN, Anderson MS. (1974). Myopathic changes in amyotrophic lateral sclerosis. Pathologic analysis of muscle biopsy changes in 111 cases. Neurology 24:477–81.
- Allicotti G, Borras E, Pinilla C. (2003). A time-resolved fluorescence immunoassay (DELFIA) increases the sensitivity of antigen-driven cytokine detection. J Immunoassay Immunochem 24:345–58.
- Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH, Hardiman O. (2006). Elevated serum angiogenin levels in ALS. Neurology 67:1833–6.
- Dupuis L, Gonzalez De Aguilar JL, Di Scala F, Rene F, De Tapia M, Pradat PF, Lacomblez L, Seihlan D, Prinjha R, Walsh FS, Meininger V, Loeffler JP. (2002). Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 10:358–65.
- Fournier AE, Grandpre T, Strittmatter SM, (2001). Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341–6.
- Iwata NK, Aoki S, Okabe S, Arai N, Terao Y, Kwak S, Abe O, Kanazawa I, Tsuji S, Ugawa Y. (2008). Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 70:528–32.
- Jokic N, Gonzalez De Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, Muller A, Dubourg O, Seilhean D, Hauw JJ, Loeffler JP, Meininger V. (2005). Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 57:553–6.
- Liu BP, Cafferty WB, Budel SO, Strittmatter SM. (2006). Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 361:1593–610.
- Magnusson C, Libelius R, Tagerud S. (2003). Nogo (Reticulon 4) expression in innervated and denervated mouse skeletal muscle. Mol Cell Neurosci 22:298–307.
- Oertle T, Schwab ME. (2003). Nogo and its paRTNers. Trends Cell Biol 13:187–94.
- Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L. (2006). Identification of potential CSF biomarkers in ALS. Neurology 66:1218–22.
- Pradat PF, Bruneteau G, Gonzalez De Aguilar JL, Dupuis L, Jokic N, Salachas F, Le Forestier N, Echaniz-Laguna A, Dubourg O, Hauw JJ, Tranchant C, Loeffler JP, Meininger V. (2007). Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann Neurol 62:15–20.
- Rodriguez-Feo JA, Hellings WE, Verhoeven BA, Moll FL, De Kleijn DP, Prendergast J, Gao Y, Van Der Graaf Y, Tellides G, Sessa WC, Pasterkamp G. (2007). Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity. Arterioscler Thromb Vasc Biol 27:1354–60.
- Tagerud S, Libelius R, Magnusson C. (2007). Muscle Nogo-A: a marker for amyotrophic lateral sclerosis or for denervation? Ann Neurol 62:676.
- Teng FY, Tang BL. (2008). Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis. J Cell Mol Med 12:1199–204.
- Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA, Strittmatter SM. (2002). Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 22:5505–15.
- Wojcik S, Engel WK, Askanas V. (2006). Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease. Acta Myol 25:116–18.
- Yang YS, Strittmatter SM. (2007). The reticulons: a family of proteins with diverse functions. Genome Biol 8:234.